ARK Invest Biotech Active

ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF’s (“Fund”) investment objective is long-term growth of capital.

$25.66

-11.0% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
ARK Genomic Revolution ETF ARKG
Fund Size
$1.66 Billion
Dividend
0.0%
Fees
0.75%
ARK Innovation ETF ARKK
Fund Size
$7.55 Billion
Dividend
0.0%
Fees
0.75%
ARK Next Generation Internet ETF ARKW
Fund Size
$1.53 Billion
Dividend
0.0%
Fees
0.75%
ARK Fintech Innovation ETF ARKF
Fund Size
$1.03 Billion
Dividend
0.0%
Fees
0.75%
ARK Autonomous Technology & Robotics ETF ARKQ
Fund Size
$932 Million
Dividend
0.0%
Fees
0.75%
View 9 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $38.9 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.03 %
Beta Indicates the relationship between the price performance of a share and the market. 1.4845
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 42.6
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -15.41
Profitable Companies 9
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 28.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 8.26
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 5.02
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -9.27
Enterprise Value to Revenue Enterprise value divided by revenue 8.13
Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.604
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -155.76%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -37.71%
Return on Assets Indicates a company's profitability in relation to its total assets. -19.31%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -21.76%

Industries

Healthcare 79.1%
Technology 11.6%
Other 7.0%
N/A 2.3%

Market cap

Micro Cap 7%
Small Cap 38%
Mid Cap 41%
Large Cap 13%
Mega Cap 1%

43 Investments

P/E-Ratio
Total Investment
Weight
Exact Sciences Corp logo

EXAS - Professional, Scientific, and Technical Services

Exact Sciences Corp

P/E-Ratio
-39.9
Total Investment
$135 Million
Weight
8.2%
CRISPR Therapeutics AG logo

CRSP - Manufacturing

CRISPR Therapeutics AG

P/E-Ratio
-21.8
Total Investment
$109 Million
Weight
6.6%
Twist Bioscience Corp logo

TWST - Professional, Scientific, and Technical Services

Twist Bioscience Corp

P/E-Ratio
-14.1
Total Investment
$86.3 Million
Weight
5.2%
Recursion Pharmaceuticals Inc logo

RXRX - Professional, Scientific, and Technical Services

Recursion Pharmaceuticals Inc

P/E-Ratio
-6.1
Total Investment
$81.1 Million
Weight
4.9%
Ionis Pharmaceuticals Inc logo

IONS - Manufacturing

Ionis Pharmaceuticals Inc

P/E-Ratio
-14.3
Total Investment
$75.6 Million
Weight
4.6%
Teladoc Health Inc logo

TDOC - Health Care and Social Assistance

Teladoc Health Inc

P/E-Ratio
-9.4
Total Investment
$73.3 Million
Weight
4.4%
Pacific Biosciences of Califor logo

PACB - Manufacturing

Pacific Biosciences of Califor

P/E-Ratio
-2.0
Total Investment
$73 Million
Weight
4.4%
Schrodinger Inc/United States logo

SDGR - Manufacturing

Schrodinger Inc/United States

P/E-Ratio
-10.2
Total Investment
$68.5 Million
Weight
4.1%
Accolade Inc logo

ACCD - Information

Accolade Inc

P/E-Ratio
-5.8
Total Investment
$65.4 Million
Weight
3.9%
Ginkgo Bioworks Holdings Inc logo

SRNGU - Manufacturing

Ginkgo Bioworks Holdings Inc

P/E-Ratio
0.0
Total Investment
$60.7 Million
Weight
3.7%
Arcturus Therapeutics Holdings logo

ARCT - Manufacturing

Arcturus Therapeutics Holdings

P/E-Ratio
-7.7
Total Investment
$57.3 Million
Weight
3.5%
10X Genomics Inc logo

TXG - Professional, Scientific, and Technical Services

10X Genomics Inc

P/E-Ratio
-10.2
Total Investment
$54 Million
Weight
3.3%
Beam Therapeutics Inc logo

BEAM - Manufacturing

Beam Therapeutics Inc

P/E-Ratio
-14.5
Total Investment
$53.8 Million
Weight
3.3%
CareDx Inc logo

CDNA - Health Care and Social Assistance

CareDx Inc

P/E-Ratio
-4.2
Total Investment
$51.6 Million
Weight
3.1%
Intellia Therapeutics Inc logo

NTLA - Manufacturing

Intellia Therapeutics Inc

P/E-Ratio
-5.2
Total Investment
$49.4 Million
Weight
3.0%
Veracyte Inc logo

VCYT - Health Care and Social Assistance

Veracyte Inc

P/E-Ratio
-26.2
Total Investment
$48.6 Million
Weight
2.9%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
28.3
Total Investment
$43.6 Million
Weight
2.6%
Veeva Systems Inc logo

VEEV - Manufacturing

Veeva Systems Inc

P/E-Ratio
64.5
Total Investment
$39.9 Million
Weight
2.4%
Adaptive Biotechnologies Corp logo

ADPT - Manufacturing

Adaptive Biotechnologies Corp

P/E-Ratio
-2.5
Total Investment
$39.9 Million
Weight
2.4%
UiPath Inc logo

PATH - Information

UiPath Inc

P/E-Ratio
-110.5
Total Investment
$36.8 Million
Weight
2.2%
Moderna Inc logo

MRNA - Manufacturing

Moderna Inc

P/E-Ratio
-8.5
Total Investment
$35.2 Million
Weight
2.1%
Verve Therapeutics Inc logo

VERV - Professional, Scientific, and Technical Services

Verve Therapeutics Inc

P/E-Ratio
-2.6
Total Investment
$31.5 Million
Weight
1.9%
Standard BioTools Inc logo

FLDM - Manufacturing

Standard BioTools Inc

P/E-Ratio
-4.9
Total Investment
$30.5 Million
Weight
1.8%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
17.1
Total Investment
$26.5 Million
Weight
1.6%
908 Devices Inc logo

MASS - Manufacturing

908 Devices Inc

P/E-Ratio
-6.8
Total Investment
$25.8 Million
Weight
1.6%